<DOC>
	<DOCNO>NCT00283309</DOCNO>
	<brief_summary>The primary purpose determine patient schedule receive prescription corticosteroid therapy inflammatory illness give either memantine riluzole pretreatment show lesser declarative memory impairment receive placebo . The exploratory purpose determine patient schedule receive prescription corticosteroid therapy inflammatory illness give memantine riluzole pretreatment show small increase manic/hypomanic symptom severity receive placebo .</brief_summary>
	<brief_title>Memantine Riluzole Prophylaxis Corticosteroid-induced Mood Declarative Memory Changes</brief_title>
	<detailed_description>Twenty five ( 25 ) outpatient pulmonary ( e.g . asthma , cystic fibrosis ) rheumatic ( e.g . rheumatoid arthritis , dermatomyositis ) illnesses schedule receive brief course ( `` burst '' ) prednisone enrol . The subject randomize receive memantine , riluzole placebo begin immediately prior corticosteroid therapy continue one week . Measures cognition mood compare two group baseline , day 3 , day 7 . Demographic information include age , gender , frequency duration prior corticosteroid therapy current anticipate dose duration collect baseline . Baseline measure mood assessed Activation subscale Internal State Scale ( ISS ) ( primary measure ) , Hamilton Depression Rating Scale ( 17-item version ) , Young Mania Rating Scale ( YMRS ) . Cognition assess RAVLT ( primary measure ) , Stroop , Digit Span Backwards . The subject give memantine ( 10 mg ) , riluzole ( 50 mg ) , identical appear placebo 1 tablet daily 3 day first follow appointment ( day 3 ) dose increase BID side effect report . The subject reassess twice , day 3 day 7 . Mood cognitive measure repeat . The study visit last approximately hour half . Participants discontinue memantine discontinue prednisone . The RA administer assessment blind time . Alternative equivalent version RAVLT Digit Span Backwards give minimize practice learn effect . Current cumulative corticosteroid dose ( mg day X number day ) determine record . HVLT-R test total word recall score compare baseline exit active medication phase placebo phase use within subject design pair t-tests . Based prior experience work corticosteroid-dependent patient find compliant clinical treatment . Thus , anticipate large number dropouts miss data . In case miss data use last observation carry forward . In lamotrigine study similar population , find change total word recall word list Stroop . Assuming similar change memantine , use double-sided , paired t-tests , could detect difference change placebo group participants HVLT-R participant Stroop . Thus , although primarily pilot study obtain effect size future , large trial fund NIH , power detect clinically meaningful difference medication placebo .</detailed_description>
	<mesh_term>Memory Disorders</mesh_term>
	<mesh_term>Memantine</mesh_term>
	<mesh_term>Riluzole</mesh_term>
	<criteria>1870 year old English speaking Able provide inform consent Scheduled receive corticosteroid burst least 20 mg prednisone equivalent least 7 day History allergic reaction memantine and/or riluzole Pregnant nursing woman History liver disease , myocardial infarction , renal failure , diabetes poor glycemic control , unstable medical condition Mental retardation , dementia , severe cognitive disorder Prior prednisone therapy last 14 day Current alcohol/substance abuse/dependence</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Corticosteroids</keyword>
	<keyword>Riluzole</keyword>
	<keyword>Memantine</keyword>
	<keyword>Memory</keyword>
</DOC>